Your browser doesn't support javascript.
loading
Influenza virus infection causes global RNAPII termination defects.
Zhao, Nan; Sebastiano, Vittorio; Moshkina, Natasha; Mena, Nacho; Hultquist, Judd; Jimenez-Morales, David; Ma, Yixuan; Rialdi, Alex; Albrecht, Randy; Fenouil, Romain; Sánchez-Aparicio, Maria Teresa; Ayllon, Juan; Ravisankar, Sweta; Haddad, Bahareh; Ho, Jessica Sook Yuin; Low, Diana; Jin, Jian; Yurchenko, Vyacheslav; Prinjha, Rab K; Tarakhovsky, Alexander; Squatrito, Massimo; Pinto, Dalila; Allette, Kimaada; Byun, Minji; Smith, Melissa Laird; Sebra, Robert; Guccione, Ernesto; Tumpey, Terrence; Krogan, Nevan; Greenbaum, Benjamin; van Bakel, Harm; García-Sastre, Adolfo; Marazzi, Ivan.
Afiliación
  • Zhao N; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  • Sebastiano V; Global Health and Emerging Pathogens Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  • Moshkina N; Department of Obstetrics and Gynecology, Stanford University, Stanford, CA, USA.
  • Mena N; Institute for Stem Cell Biology & Regenerative Medicine, Stanford University, Stanford, CA, USA.
  • Hultquist J; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  • Jimenez-Morales D; Global Health and Emerging Pathogens Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  • Ma Y; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  • Rialdi A; Global Health and Emerging Pathogens Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  • Albrecht R; Department of Medicine (Infectious Diseases), Northwestern University Feinberg School of Medicine, Chicago, IL, USA.
  • Fenouil R; Department of Cellular and Molecular Pharmacology, University of California, San Francisco, San Francisco, CA, USA.
  • Sánchez-Aparicio MT; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  • Ayllon J; Global Health and Emerging Pathogens Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  • Ravisankar S; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  • Haddad B; Global Health and Emerging Pathogens Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  • Ho JSY; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  • Low D; Global Health and Emerging Pathogens Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  • Jin J; Icahn Institute for Genomics and Multiscale Biology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  • Yurchenko V; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  • Prinjha RK; Global Health and Emerging Pathogens Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  • Tarakhovsky A; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  • Squatrito M; Global Health and Emerging Pathogens Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  • Pinto D; Department of Obstetrics and Gynecology, Stanford University, Stanford, CA, USA.
  • Allette K; Institute for Stem Cell Biology & Regenerative Medicine, Stanford University, Stanford, CA, USA.
  • Byun M; Department of Obstetrics and Gynecology, Stanford University, Stanford, CA, USA.
  • Smith ML; Institute for Stem Cell Biology & Regenerative Medicine, Stanford University, Stanford, CA, USA.
  • Sebra R; Institute of Molecular and Cell Biology (IMCB), Agency for Science, Technology and Research (A*STAR), Singapore, Singapore.
  • Guccione E; Institute of Molecular and Cell Biology (IMCB), Agency for Science, Technology and Research (A*STAR), Singapore, Singapore.
  • Tumpey T; Mount Sinai Center for Therapeutics Discovery, Departments of Pharmacological Sciences and Oncological Sciences, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  • Krogan N; Life Science Research Centre, Faculty of Science, University of Ostrava, Ostrava, Czech Republic.
  • Greenbaum B; Epinova Epigenetics Discovery Performance Unit, Immuno-Inflammation Therapy Area, GlaxoSmithKline, Medicines Research Centre, Stevenage, UK.
  • van Bakel H; Laboratory of Immune Cell Epigenetics and Signaling, The Rockefeller University, New York, NY, USA.
  • García-Sastre A; Cancer Cell Biology Programme, Centro Nacional de Investigaciones Oncológicas, CNIO, Madrid, Spain.
  • Marazzi I; Department of Psychiatry, Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Nat Struct Mol Biol ; 25(9): 885-893, 2018 09.
Article en En | MEDLINE | ID: mdl-30177761
ABSTRACT
Viral infection perturbs host cells and can be used to uncover regulatory mechanisms controlling cellular responses and susceptibility to infections. Using cell biological, biochemical, and genetic tools, we reveal that influenza A virus (IAV) infection induces global transcriptional defects at the 3' ends of active host genes and RNA polymerase II (RNAPII) run-through into extragenic regions. Deregulated RNAPII leads to expression of aberrant RNAs (3' extensions and host-gene fusions) that ultimately cause global transcriptional downregulation of physiological transcripts, an effect influencing antiviral response and virulence. This phenomenon occurs with multiple strains of IAV, is dependent on influenza NS1 protein, and can be modulated by SUMOylation of an intrinsically disordered region (IDR) of NS1 expressed by the 1918 pandemic IAV strain. Our data identify a strategy used by IAV to suppress host gene expression and indicate that polymorphisms in IDRs of viral proteins can affect the outcome of an infection.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: ARN Polimerasa II / Regiones Terminadoras Genéticas / Gripe Humana Tipo de estudio: Etiology_studies Límite: Humans Idioma: En Revista: Nat Struct Mol Biol Asunto de la revista: BIOLOGIA MOLECULAR Año: 2018 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: ARN Polimerasa II / Regiones Terminadoras Genéticas / Gripe Humana Tipo de estudio: Etiology_studies Límite: Humans Idioma: En Revista: Nat Struct Mol Biol Asunto de la revista: BIOLOGIA MOLECULAR Año: 2018 Tipo del documento: Article País de afiliación: Estados Unidos